NACDS, NCPA Thank Patient, Consumer Groups for Taking Important Stance on DIR Fee Reform Groups emphasize DIR fee reform’s power to reduce out-of-pocket drug costs and to reduce overall healthcare costs as a result of medication adherence and better health

2019-02-12T17:08:10+00:00Feb-12-19|Categories: Press Release|Tags: , , , , |

NACDS and the National Community Pharmacists Association (NCPA) today lauded 24 patient and consumer groups for advocating for pharmacy direct and indirect remuneration (DIR) fee reform.

NACDS, NCPA Praise Senate Action to Reduce Patient Drug Costs Bipartisan Senate letter to HHS Secretary urges swift action on pharmacy DIR fee reform to lower out-of-pocket drug costs for patients and to stop unworkable practices that are unfair to pharmacies

2019-02-12T17:08:57+00:00Feb-05-19|Categories: Press Release|Tags: , , , , |

NACDS and the National Community Pharmacists Association (NCPA) today praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar.

NACDS Welcomes 2019 National Drug Control Strategy, Affirms Pharmacy’s Absolute Commitment to Drug Abuse Prevention Strategy touches on key aspects of NACDS’ public policy recommendations

2019-02-12T17:10:10+00:00Feb-04-19|Categories: Press Release|Tags: |

NACDS today welcomed the White House’s release of the 2019 National Drug Control Strategy, and expressed in particular the Association’s commitment to collaboration as part of the solution to the opioid-abuse epidemic.

DIR Fee Reform, Reimbursement Issues Front-and-Center at NACDS Regional Chain Conference Event also features insights and collaboration on diverse health-and-wellness and front-end topics

2019-02-04T11:27:37+00:00Feb-04-19|Categories: Press Release|Tags: , , |

Rebecca Bubel, RPh, 2019 NACDS Regional Chain Conference chair and senior director of store operations, Kinney Drugs, Inc.

The National Association of Chain Drug Stores’ (NACDS) campaign-style approach to […]

NACDS Advances Pharmacy in New York Times Letter-to-the-Editor NACDS President & CEO Steven C. Anderson responds to column, “The Unsung Role of the Pharmacist in Patient Health”

2019-02-12T17:12:23+00:00Jan-31-19|Categories: Press Release|Tags: , |

NACDS has provided a response to “The Unsung Role of the Pharmacist in Patient Health,” a New York Times article published on Jan. 28 that emphasizes the increasingly important role of pharmacists in healthcare delivery.

NACDS Provides Input on HHS’ Healthy People 2030 Initiative Highlights pharmacists’ increasing role as trusted, accessible and effective healthcare providers

2019-02-12T17:12:15+00:00Jan-28-19|Categories: Press Release|Tags: , |

NACDS has submitted comments containing recommendations for the Department of Health and Human Services’ (HHS) Healthy People 2030 initiative, which develops a new set of evidence-based, 10-year national objectives aimed at improving the health of all Americans.

NACDS Demonstrates Need for DIR Fee Reform in Comments to CMS Supports agency proposal to reduce patients’ out-of-pocket drug costs, reduce overall healthcare costs, improve patient health, and address drastically unfair reimbursement to pharmacies

2019-02-28T16:34:35+00:00Jan-25-19|Categories: Press Release|Tags: , , , , |

Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented

Patient Safety Key as NACDS and APhA Oppose Prescription Drug Importation Emphasize commitment to safer, more effective strategies to reduce drug prices and increase access to prescription medications

2019-02-12T17:13:56+00:00Jan-18-19|Categories: Press Release|Tags: , |

NACDS and the American Pharmacists Association (APhA) expressed concerns about the risks to patient health and the security of the prescription drug supply chain in opposing legislation that would allow for personal and commercial importation of prescription drugs outside of the Food and Drug Administration’s (FDA) oversight.

Load More Posts